Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
María Trojano(University of Bari Aldo Moro), Paolo Livrea(University of Bari Aldo Moro), Giovanni Defazio(Istituto Neurologico Mediterraneo), Carlo Avolio(University of Foggia), Maria Liguori(University of Bari Aldo Moro), Maddalena Ruggieri(University of Bari Aldo Moro), Damiano Paolicelli(University of Bari Aldo Moro), Maria Pia Santacroce(University of Bari Aldo Moro), Paolo Riccio(University of Basilicata), Fabrizio Giuliani(University of Alberta), Grazia Maria Liuzzi(University of Bari Aldo Moro)
Cited by 127
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|Nature Medicine|2007|1.8k
Multiple Sclerosis Severity Score
|Neurology|2005|959
The Role of Inflammation in Depression and Fatigue
|Frontiers in Immunology|2019|651
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624